Reasanz
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Reasanz, covering 2014-09-01 to 2014-09-01. Get the full timeline:
Most recent: EMA Refused: Reasanz (serelaxin) — Novartis Europharm Ltd
1 regulatory and trial event tracked for Reasanz, covering 2014-09-01 to 2014-09-01. Get the full timeline:
Most recent: EMA Refused: Reasanz (serelaxin) — Novartis Europharm Ltd